Skip to main content

Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study

Publication ,  Conference
Szabolcs, P; Visani, G; Locatelli, F; Kleiner, G; Talano, J; Nemecek, ER; Kurtzberg, J
Published in: BONE MARROW TRANSPLANTATION
March 1, 2010

Duke Scholars

Published In

BONE MARROW TRANSPLANTATION

ISSN

0268-3369

Publication Date

March 1, 2010

Volume

45

Start / End Page

S18 / S18

Location

Vienna, AUSTRIA

Publisher

NATURE PUBLISHING GROUP

Conference Name

36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Szabolcs, P., Visani, G., Locatelli, F., Kleiner, G., Talano, J., Nemecek, E. R., & Kurtzberg, J. (2010). Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. In BONE MARROW TRANSPLANTATION (Vol. 45, pp. S18–S18). Vienna, AUSTRIA: NATURE PUBLISHING GROUP.
Szabolcs, P., G. Visani, F. Locatelli, G. Kleiner, J. Talano, E. R. Nemecek, and J. Kurtzberg. “Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study.” In BONE MARROW TRANSPLANTATION, 45:S18–S18. NATURE PUBLISHING GROUP, 2010.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek ER, et al. Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. In: BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2010. p. S18–S18.
Szabolcs P, Visani G, Locatelli F, Kleiner G, Talano J, Nemecek ER, Kurtzberg J. Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study. BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2010. p. S18–S18.

Published In

BONE MARROW TRANSPLANTATION

ISSN

0268-3369

Publication Date

March 1, 2010

Volume

45

Start / End Page

S18 / S18

Location

Vienna, AUSTRIA

Publisher

NATURE PUBLISHING GROUP

Conference Name

36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting

Related Subject Headings

  • Immunology
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences